期刊文献+

血清C-反应蛋白、尿酸和血脂检测在冠心病中的联合应用 被引量:2

Combined application of serum C-reactive protein,uric acid and serum lipids in patients with the coronary heart diseases
原文传递
导出
摘要 目的:探讨冠心病患者血清C-反应蛋白、尿酸与血脂联合检测的临床应用价值。方法:检测107例冠心病患者(40例急性心肌梗死、38例不稳定性心绞痛、29例稳定性心绞痛)血清脂类[TC、TG、HDL-C、LDL-C、ApoA、ApoB和Lp(a)]、C-反应蛋白(CRP)和尿酸(UA),并与40例健康对照组的对应指标进行比较。结果:稳定性心绞痛组、不稳定性心绞痛组和急性心肌梗死组CRP、UA、TC、TG、LDL-C、ApoB、Lp(a)水平均高于对照组;除稳定性心绞痛组的ApoA外,观察组的血清HDL-C、ApoA水平均明显低于对照组,且CRP和UA与TC、TG、LDL-C、ApoB、Lp(a)呈正相关,与HDL-C、ApoA呈负相关。结论:冠心病患者血清C-反应蛋白和尿酸与血脂代谢异常有相关性,三者联合检测对冠心病的预防、诊断及预后判断具有重要的临床价值。 Objective:To study the clinical application value of combination detection of serum C-reactive protein(CRP),uric acid(UA) and lipids in patients with the coronary heart diseases.Method:The serum CRP,UA and serum lipids [ TC,TG,HDL-C,LDL-C,ApoA,ApoB,Lp(a)] of 107 cases of coronary artery diseases(including 40 cases of AMI,38 cases of USA and 29 cases of SA) and 40 cases of control group were detected and analyzed by t test.Results:The level of serum CRP,UA,TG,TC,LDL-C,Lp(a) and ApoB in patients with SA,USA and AMI were more higher than that of the healthy group,and the level of CRP and UA had positive relativity with TG,TC,LDL-C,Lp(a),ApoB;except for ApoA in 29 cases of SA,HDL-C and ApoA descended evidently,and the level of CRP and UA had negative relativity with HDL-C and ApoA.Conclusion:The serum CRP and UA have relationship with abnormal of serum lipids and the combined application of serum CRP,UA and lipids has more important significance for the diagnosis,therapy and prognosis of coronary heart diseases.
作者 周长邵
出处 《福州总医院学报》 2011年第4期218-219,202,共3页 Journal of Fuzhou General Hospital
关键词 冠心病 C反应蛋白 尿酸 血脂 coronary heart diseases C-reactive protein uric acid serum lipid
  • 相关文献

参考文献10

  • 1迟小伟,刘杰.hs-CRP、IL-6、TNF-α在心血管疾病中的意义[J].医学检验与临床,2008,20(3):50-51. 被引量:10
  • 2孙静,周立平,刘允桂,孙明喜,巴静.血清尿酸和C-反应蛋白水平与冠心病关系的探讨[J].中国实验诊断学,2008,12(4):501-502. 被引量:1
  • 3张公民,周增荣,张秧花.108例冠心病患者的血脂分析和hs-CRP测定的临床应用[J].放射免疫学杂志,2008,21(1):17-18. 被引量:5
  • 4郑刚,张善春,张德铭,黄自平.高尿酸血症与冠状动脉病变关系的探讨[J].中国心血管病研究,2006,4(9):677-679. 被引量:9
  • 5Coutinho Tde A,Turner ST,Peyser PA,et al.Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. American Journal of Hypertension . 2007
  • 6Bickel C,Rupprecht HJ,Blankenberg S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease. The American Journal of Cardiology . 2002
  • 7Niskanen LK,Laaksonen DE,Nyyssonen K, et al.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Archives of Internal Medicine . 2004
  • 8Yong-Woo P,Shankuan Z,Latha P,et al.The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Archives of Internal Medicine . 2003
  • 9Almagor M,Keren A,Banai S.Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. American Heart Journal . 2003
  • 10RG Craig.Relationship of destructive periodontal disease to the acute-phase response. Journal of Periodontology . 2003

二级参考文献21

  • 1郑刚,张承宗.解读急性冠状动脉综合征他汀类药物治疗作用的临床证据(二)[J].中国心血管病研究,2004,2(7):491-492. 被引量:12
  • 2[1]Bickel C,Rupprecht HJ,Blankenbery S,et al.Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.Am J Cardiol,2002,89:12-17.
  • 3[2]Niskanen LK,Laaksonen DE,Nyyssonen K,et al.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study.Arch Intern Med,2004,164:1546-1551.
  • 4[5]Park YW,Zhu S,Palaniappan L,et al.The metabolic syndrome:prevalence and associated risk factor finding in the US population from the third national health and nutrition examination survey 1988-1994.Arch Intern Med,2003,163:407-413.
  • 5[6]Sundstrom J,Sullivan L,D'Agostino RB,et al.Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.Hypertension,2005,45:28-33.
  • 6[7]Costa A,Iguala I,Bedini J,et al.Serum uric acid concentration in subjects at risk of type 2 diabetes mellitus:relationship to components of the metabolic syndrome.Metabolism,2002,51:372-375.
  • 7[8]Bo S,Cavallo-Perin P,Gentile L,et al.Hypouricemia and hyperuricemia in type 2 diabetes:two different phenotypes.Eur J Clin Invest,2001,31:318-321.
  • 8Braumwald E, Antrman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non - ST - segement elevation myocardial infarction, a report of American college of cardiology/American Heart Association task force or practice guideline. J Am Coll Cariol. 2000, 36(3) :970.
  • 9Steinberg D, Pathsarathy S, carew rITE, et al. Beyond cholesterol: Modification of low - density lipoprotein that increase its atherogenieity. N Engl J Med. 1989,320:915.
  • 10Brand FN, McGee DL, Kannel WB, et al. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study[J]. Am J Epidemiol, 1985, 121(1):11.

共引文献21

同被引文献16

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部